Nichole  Tanner  to  Adult
                            
                            
                                This is a "connection" page, showing publications  Nichole  Tanner  has written about  Adult.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.211
         
        
        
     
 
    
        
        - 
            Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017 08; 152(2):263-270.
            
            
                Score: 0.039
            
         
        
        - 
            Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015 Dec; 148(6):1405-1414.
            
            
                Score: 0.036
            
         
        
        - 
            Attitudes and beliefs toward lung cancer screening among US Veterans. Chest. 2013 Dec; 144(6):1783-1787.
            
            
                Score: 0.031
            
         
        
        - 
            Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study. Ann Intern Med. 2022 Nov; 175(11):1501-1505.
            
            
                Score: 0.014
            
         
        
        - 
            Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for?Moderate Sedation During Bronchoscopy. Chest. 2019 01; 155(1):137-146.
            
            
                Score: 0.011
            
         
        
        - 
            Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2018 07 15; 198(2):e3-e13.
            
            
                Score: 0.011
            
         
        
        - 
            Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2018 09; 154(3):491-500.
            
            
                Score: 0.010
            
         
        
        - 
            ATS Core Curriculum 2017: Part IV. Adult Pulmonary Medicine. Ann Am Thorac Soc. 2017 08; 14(Suppl_2):S196-S208.
            
            
                Score: 0.010
            
         
        
        - 
            Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival. Chest. 2017 09; 152(3):587-597.
            
            
                Score: 0.010
            
         
        
        - 
            Factors that influence physician decision making for indeterminate pulmonary nodules. Ann Am Thorac Soc. 2014 Dec; 11(10):1586-91.
            
            
                Score: 0.008
            
         
        
        - 
            Outcome of patients with negative and unsatisfactory cytologic specimens obtained by endobronchial ultrasound-guided transbronchial fine-needle aspiration of mediastinal lymph nodes. Cancer Cytopathol. 2015 Feb; 123(2):92-7.
            
            
                Score: 0.008
            
         
        
        - 
            Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Chest. 2014 Aug; 146(2):406-411.
            
            
                Score: 0.008
            
         
        
        - 
            The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest. 2014 Mar 01; 145(3):464-472.
            
            
                Score: 0.008
            
         
        
        - 
            Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest. 2011 Dec; 140(6):1550-1556.
            
            
                Score: 0.007